These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9351911)

  • 1. Pharmacokinetics of recombinant human insulin-like growth factor-I in diabetic rats.
    Higaki K; Matsumoto Y; Fujimoto R; Kurosaki Y; Kimura T
    Drug Metab Dispos; 1997 Nov; 25(11):1324-7. PubMed ID: 9351911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental changes in pharmacokinetics of recombinant human insulin-like growth factor-I in rats.
    Higaki K; Matsumoto Y; Fujimoto R; Kurosaki Y; Kimura T
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):115-24. PubMed ID: 9344224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
    Han HJ; Kang CW; Park SH
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].
    Kato M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):613-25. PubMed ID: 10036618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of recombinant human insulin-like growth factor-I in normal and hypophysectomized rats.
    Kimura T; Kanzaki Y; Matsumoto Y; Mandai M; Kurosaki Y; Nakayama T
    Biol Pharm Bull; 1994 Feb; 17(2):310-5. PubMed ID: 7515746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats.
    Zapf J; Hauri C; Futo E; Hussain M; Rutishauser J; Maack CA; Froesch ER
    J Clin Invest; 1995 Jan; 95(1):179-86. PubMed ID: 7529258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3).
    Sommer A; Spratt SK; Tatsuno GP; Tressel T; Lee R; Maack CA
    Growth Regul; 1993 Mar; 3(1):46-9. PubMed ID: 7683528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of free insulin-like growth factor-I in healthy subjects.
    Frystyk J; Hussain M; Skjaerbaek C; Pørksen N; Froesch ER; Orskov H
    Growth Horm IGF Res; 1999 Apr; 9(2):150-6. PubMed ID: 10373348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal absorption of recombinant human insulin-like growth factor-I in rats.
    Kimura T; Murakawa Y; Ohno M; Ohtani S; Higaki K
    J Pharmacol Exp Ther; 1997 Nov; 283(2):611-8. PubMed ID: 9353376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.
    Lieberman SA; Bukar J; Chen SA; Celniker AC; Compton PG; Cook J; Albu J; Perlman AJ; Hoffman AR
    J Clin Endocrinol Metab; 1992 Jul; 75(1):30-6. PubMed ID: 1377706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
    Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
    Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F; Lang K; Dony C; Kling L
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
    Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
    Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
    Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free and protein-bound insulin-like growth factor-I (IGF-I) and IGF-binding proteins in plasma of coho salmon, Oncorhynchus kisutch.
    Shimizu M; Swanson P; Dickhoff WW
    Gen Comp Endocrinol; 1999 Sep; 115(3):398-405. PubMed ID: 10480991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of rhIGF-I/IGFBP-3 in the rat and monkey.
    Adams S; Moore J; Chu S; Bagi C; DeLeon L; Liu C; Schmidt D; Sommer A
    Prog Growth Factor Res; 1995; 6(2-4):347-56. PubMed ID: 8817678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
    Clemmons DR; Sleevi M; Allan G; Sommer A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexin43 expression in vitro.
    Aberg ND; Blomstrand F; Aberg MA; Björklund U; Carlsson B; Carlsson-Skwirut C; Bang P; Rönnbäck L; Eriksson PS
    J Neurosci Res; 2003 Oct; 74(1):12-22. PubMed ID: 13130502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of insulin-like growth factor binding protein-2 as a biochemical surrogate marker for the in vivo effects of recombinant human insulin-like growth factor-1 in mice.
    Bhat RV; Engber TM; Zhu Y; Miller MS; Contreras PC
    J Pharmacol Exp Ther; 1997 Apr; 281(1):522-30. PubMed ID: 9103540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.